Abstract Session: Biomarkers and immune monitoring
Tuesday September 24, 2024 from 10:40 to 12:10
Emirgan 1
Click for details – page will open in a new window
Moderators
Dr. Aravind Cherukuri, United States
Kate Bramham, United Kingdom
Lectures
321.a Tracking the effectors of allograft rejection
Alexandra Sharland, Australia
321.1 B cell phenotypes in peripheral blood of patients with renal allograft
Prof. Suzanne J Hodgkinson, Australia
321.2 Clinical utility of donor-derived cell-free DNA during the period of recovery of renal function after kidney transplantation
Mr. Pedro H. Oliveira Sr., Brazil
321.3 Assessment of antibodies against SARS-COV2 using the Luminex technique after vaccination in kidney transplant recipients
Dr. Patricia D'Almeida Bianco, Brazil
321.4 Cell-free DNA testing – A new arrow in the ID doctor’s quiver? Or a stewardship nightmare?
Prof. Cameron Wolfe, United States
321.5 Circulating cell-free DNA in liver transplantation: A pre- and post-transplant biomarker of graft dysfunction
Dr. Tullia Carradori, Italy
321.6 Impact of Gd-IgA1 predict of recurrent IgA nephropathy after kidney transplantation
Dr. Cheng-Hsu Chen, Taiwan
321.7 Construct and validate a mortality prediction model for severe pulmonary infection post-kidney transplantation
Prof. Puxun Tian, People's Republic of China